Literature DB >> 95731

A common familial component in lung cancer and chronic obstructive pulmonary disease.

B H Cohen1, E L Diamond, C G Graves, P Kreiss, D A Levy, H A Menkes, S Permutt, S Quaskey, M S Tockman.   

Abstract

First-degree relatives of lung-cancer patients and of patients with chronic obstructive pulmonary disease had significantly higher age-sex-race-smoking-adjusted rates of impaired forced expiration than first-degree relatives of patients with non-pulmonary disease or community-derived comparison series (neighbourhood controls and teachers). Subclassification of the data and multiple adjustment for smoking, race, sex, and other confounding factors emphasised the consistency of the pattern. These findings strongly suggest that lung cancer and chronic obstructive pulmonary disease share a common familial component other than smoking. The clinical manifestation may depend on the presence of one or more other cofactors as yet undefined.

Entities:  

Mesh:

Year:  1977        PMID: 95731     DOI: 10.1016/s0140-6736(77)90663-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  31 in total

Review 1.  Genetics and pulmonary medicine. 9. Molecular genetics of chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

Review 2.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

Review 3.  Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.

Authors:  D T Purtilo; L Paquin; T Gindhart
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

4.  The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.

Authors:  H M Jansen; T H The; G C de Gast; M T Esselink; G Pastoor; N G Orie
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

5.  The Po River Delta epidemiological study of obstructive lung disease: sampling methods, environmental and population characteristics.

Authors:  L Carrozzi; G Giuliano; G Viegi; P Paoletti; F Di Pede; U Mammini; G Carmignani; R Saracci; C Giuntini; M D Lebowitz
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

Review 6.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

7.  G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Authors:  Junya Fujimoto; Humam Kadara; Melinda M Garcia; Mohamed Kabbout; Carmen Behrens; Diane D Liu; J Jack Lee; Luisa M Solis; Edward S Kim; Neda Kalhor; Cesar Moran; Amir Sharafkhaneh; Reuben Lotan; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

8.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Authors:  Antonello Punturieri; Eva Szabo; Thomas L Croxton; Steven D Shapiro; Steven M Dubinett
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

9.  Transcriptomic analysis of pathways regulated by toll-like receptor 4 in a murine model of chronic pulmonary inflammation and carcinogenesis.

Authors:  Alison K Bauer; Jennifer Fostel; Laura M Degraff; Elizabeth A Rondini; Christopher Walker; Sherry F Grissom; Julie Foley; Steven R Kleeberger
Journal:  Mol Cancer       Date:  2009-11-19       Impact factor: 27.401

10.  Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.

Authors:  Jill Koshiol; Melissa Rotunno; Dario Consonni; Angela Cecilia Pesatori; Sara De Matteis; Alisa M Goldstein; Anil K Chaturvedi; Sholom Wacholder; Maria Teresa Landi; Jay H Lubin; Neil E Caporaso
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.